115 studies found for:    Acromegaly
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Glucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin Resistance
Conditions: Acromegaly;   Diabetes;   Insulin Resistance;   Impaired Glucose Tolerance
Intervention:
2 Unknown  Lanreotide Levels in Acromegaly
Condition: Acromegaly
Intervention: Other: Blood draw
3 Recruiting The Treatment and Natural History of Acromegaly
Conditions: Acromegaly;   Pituitary Neoplasm
Intervention:
4 Completed Use of Somatostatin Analogue Therapy as Primary Medical Treatment of Acromegaly
Condition: Acromegaly
Intervention: Drug: Somatuline Autogel
5 Recruiting A Prospective Study of Outcome After Therapy for Acromegaly
Condition: Acromegaly
Intervention:
6 Unknown  Ultrasound Guided Sandostatin LAR Injection in Acromegaly
Condition: Acromegaly
Intervention: Drug: Sandostatin LAR
7 Completed Surgical Versus Medical Treatment of Acromegaly
Condition: Acromegaly
Intervention:
8 Recruiting Epidemiology of Acromegaly
Condition: Acromegaly
Intervention:
9 Completed Fractionated Stereotactic Radiotherapy in Patients With Acromegaly
Condition: Acromegaly
Intervention: Radiation: fractionated stereotactic radiotherapy
10 Completed Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide-LAR
11 Recruiting Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?
Condition: Acromegaly
Intervention:
12 Completed An Extension Study to Assess the Long-term Safety and Efficacy of Pasireotide in Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Pasireotide
13 Active, not recruiting Efficacy and Safety of Octreolin for Acromegaly
Condition: Acromegaly
Intervention: Drug: Active oral octreotide study drug therapy
14 Completed Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
Conditions: Carcinoid Tumor;   Acromegaly
Intervention: Drug: Pasireotide
15 Terminated Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide
16 Completed Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide LAR
17 Recruiting Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects
Conditions: Acromegaly;   Somatostatin;   Metabolism;   Signal Transduction
Intervention: Drug: GH
18 Completed Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly
Condition: Acromegaly
Interventions: Drug: Octreotide-LAR or lanreotide;   Procedure: Transsphenoidal adenomectomy
19 Active, not recruiting Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
Condition: Acromegaly
Interventions: Drug: Pasireotide;   Drug: Octreotide
20 Active, not recruiting Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment
Condition: Acromegaly
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years